跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
XTORO - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
XTORO
Authorized
STANDARD
XTORO
MerLion Pharmaceuticals GmbH
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
7abee2a4719262e3
Company
MerLion Pharmaceuticals GmbH
Type
Standard
Approval Details
Approval Id
7abee2a4719262e3
Drug Approval Canada Name
XTORO
Product Name
XTORO
Status
Approved
Status Date
2019-03-11
Din
02452928
Drug Class
Human
Dosage Form
Suspension
Route Of Administration
Otic
Schedule
Prescription
Ahfs
52:04.04
Atc Original
S02AA ANTIINFECTIVES
Atc Name
s 02 aa
Aig Number
0157930001
Company Name
MerLion Pharmaceuticals GmbH
Company Address
Robert-Roessle-Str. 10, Berlin, --, Germany, 13125
Company Detail Path
/organization/merlion-pharmaceuticals-gmbh
Company Information
Pharmaceutical Company Name
MerLion Pharmaceuticals GmbH
Country Name
Germany
Province Name
Berlin
City Name
berlin,berlin,country_de
Address
Robert-Rössle-Str. 10
Active Ingredients
FINAFLOXACIN
0.3 % / W/V
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
7abee2a4719262e3
Type
Standard
Back to Health Canada Approvals